- CO2 GRO Inc. (GROW) released positive results from a trial held at its Colombia rose greenhouse
- The trial was held in December at the Toronto-based company’s facility in Colombia
- In the four months that the study initially ran for, a total rose production increase of 8-percent was observed
- The trial is set to continue until the end of 2022
- CO2 GRO Inc. is down 18.42 percent, trading at $0.16 at 3:50 pm ET
CO2 GRO Inc. (GROW) has released positive results from a trial held at its Colombia rose greenhouse.
The trial was held in December at the Toronto-based company’s facility in Colombia.
In the four months that the study initially ran for, a total rose production increase of 8-percent was observed.
High-grade, high-value roses saw a 21-percent production increase
High-grade roses grown in the greenhouse are over 55 cm in stem length and have 6 cm wide flower buds.
The proprietary technology mists an aqueous CO2 solution directly onto plants in protected growth facilities. The technology suppresses the growth of micro-pathogens, and increases high-yield produce.
The trial is set to continue until the end of 2022.
“The trial has proved that our value proposition goes beyond simply increasing plant yields. Our CO2 Delivery Solutions technology helped increase the percentage of high-grade high value roses also. Our technology could benefit protected growers of other types of flowers, fruits, vegetables and other plants such as medicinal, to realizer greater value for a higher percentage of high-quality plants grown – enabling higher gross margins,” said vice president Aaron Archibald.
“We expect results from the second phase of this rose trial to improve with refined protocols. We also look forward to replicating these initial results at our second Colombian rose trial and a first Ecuador rose trial that we expect to commence soon.”
CO2 GRO Inc. is down 18.42 percent, trading at $0.16 at 3:50 pm ET.